Copyright
©The Author(s) 2017.
World J Clin Oncol. Apr 10, 2017; 8(2): 158-167
Published online Apr 10, 2017. doi: 10.5306/wjco.v8.i2.158
Published online Apr 10, 2017. doi: 10.5306/wjco.v8.i2.158
Figure 1 Count changes of the whole blood test.
A: Control group; B: 50 ng/kg subgroup; C: 100 ng/kg subgroup; D: 150 ng/kg subgroup; E: 200 ng/kg subgroup; F: 250 ng/kg subgroup. WBC: White blood cell; RBC: Red blood cell; PLT: Platelet.
- Citation: Guo N, Wang WQ, Gong XJ, Gao L, Yang LR, Yu WN, Shen HY, Wan LQ, Jia XF, Wang YS, Zhao Y. Study of recombinant human interleukin-12 for treatment of complications after radiotherapy for tumor patients. World J Clin Oncol 2017; 8(2): 158-167
- URL: https://www.wjgnet.com/2218-4333/full/v8/i2/158.htm
- DOI: https://dx.doi.org/10.5306/wjco.v8.i2.158